These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8588238)

  • 1. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
    Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
    Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of rapamycin.
    Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.
    Trepanier DJ; Gallant H; Legatt DF; Yatscoff RW
    Clin Biochem; 1998 Jul; 31(5):345-51. PubMed ID: 9721433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
    Yatscoff RW; LeGatt DF; Kneteman NM
    Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of therapeutic drug monitoring of rapamycin.
    Kahan BD; Napoli KL
    Transplant Proc; 1998 Aug; 30(5):2189-91. PubMed ID: 9723436
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
    Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
    Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients.
    Brattström C; Säwe J; Tydén G; Herlenius G; Claesson K; Zimmerman J; Groth CG
    Ther Drug Monit; 1997 Aug; 19(4):397-406. PubMed ID: 9263380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of rapamycin in whole blood by HPLC.
    Svensson JO; Brattström C; Säwe J
    Ther Drug Monit; 1997 Feb; 19(1):112-6. PubMed ID: 9029760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of rapamycin: single-dose studies in the rabbit.
    Honcharik N; Fryer J; Yatscoff R
    Ther Drug Monit; 1992 Dec; 14(6):475-8. PubMed ID: 1485369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of sirolimus in kidney transplant patients.
    Ferron GM; Mishina EV; Zimmerman JJ; Jusko WJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):416-28. PubMed ID: 9129559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood distribution of rapamycin.
    Yatscoff R; LeGatt D; Keenan R; Chackowsky P
    Transplantation; 1993 Nov; 56(5):1202-6. PubMed ID: 8249123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
    Johnson EM; Zimmerman J; Duderstadt K; Chambers J; Sorenson AL; Granger DK; Almond PS; Fryer Jp; Leventhal JR; Scarola J; Matas AJ; Canafax DM
    Transplant Proc; 1996 Apr; 28(2):987. PubMed ID: 8623490
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection.
    Napoli KL; Kahan BD
    Clin Chem; 1996 Dec; 42(12):1943-8. PubMed ID: 8969630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
    Brattström C; Tydén G; Säwe J; Herlenius G; Claesson K; Groth CG
    Transplant Proc; 1996 Apr; 28(2):985-6. PubMed ID: 8623489
    [No Abstract]   [Full Text] [Related]  

  • 16. Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations.
    Napoli KL; Kahan BD
    J Chromatogr B Biomed Appl; 1994 Mar; 654(1):111-20. PubMed ID: 8004232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration.
    Zimmerman JJ; Kahan BD
    J Clin Pharmacol; 1997 May; 37(5):405-15. PubMed ID: 9156373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic monitoring of cyclosporine, FK-506, and rapamycin.
    Yatscoff RW; Shaw LM
    Ther Drug Monit; 1992 Aug; 14(4):267-8. PubMed ID: 1381530
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW; Aspeslet LJ; Gallant HL
    Clin Chem; 1998 Feb; 44(2):428-32. PubMed ID: 9474055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current opinions on therapeutic drug monitoring of immunosuppressive drugs.
    Shaw LM; Holt DW; Keown P; Venkataramanan R; Yatscoff RW
    Clin Ther; 1999 Oct; 21(10):1632-52; discussion 1631. PubMed ID: 10566561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.